Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement

PURPOSE: We investigated the clinical outcome of bone marrow (BM) involvement in patients with diffuse large B-cell lymphoma (DLBCL) who received rituximab-based therapy. MATERIALS AND METHODS: A total of 567 consecutive patients with newly diagnosed DLBCL treated with rituximab-CHOP (RCHOP) between...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Byung Woog, Moon, Joon Ho, Chae, Yee Soo, Lee, Soo Jung, Kim, Jong Gwang, Kim, Yeo-Kyeoung, Lee, Je-Jung, Yang, Deok-Hwan, Kim, Hyeoung-Joon, Kim, Jin Young, Do, Young Rok, Park, Keon Uk, Song, Hong Suk, Kwon, Ki Young, Kim, Min Kyung, Lee, Kyung Hee, Hyun, Myung Soo, Ryoo, Hun Mo, Bae, Sung Hwa, Kim, Hwak, Sohn, Sang Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710960/
https://www.ncbi.nlm.nih.gov/pubmed/23864844
http://dx.doi.org/10.4143/crt.2013.45.2.112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710960/
https://www.ncbi.nlm.nih.gov/pubmed/23864844
http://dx.doi.org/10.4143/crt.2013.45.2.112

Ejemplares similares